KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

2,479
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 04,
Pre-Market

Estimated EPS

$0.32

Estimated Rev

$166.51M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
$0.32
--
--
N/A
Q2 '25
$0.22
$0.23
4.44%
BEAT
Q1 '25
$0.13
$0.11
-14.80%
MISSED
Q4 '24
$0.02
-$0.12
-598.59%
MISSED
Q3 '24
$0.02
-$0.18
-871.44%
MISSED

Latest KNSA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.